✦ LIBER ✦
Outcome of High-Risk and Refractory AML/MDS Patients Receiving a Flamsa Sequential Chemotherapy Regimen Followed by Reduced-Intensity Conditioning (RIC) and Allogeneic Hematopoeitic Stem Cell Transplantation (allo-HSCT)
✍ Scribed by M. Detrait; P. Chevallier; M. Sobh; T. Guillaume; X. Thomas; S. Morisset; N. Tedone; J. Delaunay; F. Nicolini; S. Ducastelle; Y. Chelghoum; F. Barraco; H. Labussiere; M. Mohty; M. Michallet
- Book ID
- 116283157
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 68 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.